(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Clinical trial NCT05607004 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05607004
Sponsor: Atossa Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Invasive Breast Cancer Estrogen-receptor-positive Breast Cancer HER2-negative Breast Cancer

Start date: 2023-02-14
Primary completion: 2026-11-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.